Success Metrics

Clinical Success Rate
90.0%

Based on 9 completed trials

Completion Rate
90%(9/10)
Active Trials
0(0%)
Results Posted
89%(8 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_1
1
10%
Ph phase_3
5
50%
Ph phase_4
2
20%
Ph phase_2
2
20%

Phase Distribution

1

Early Stage

2

Mid Stage

7

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
1(10.0%)
Phase 2Efficacy & side effects
2(20.0%)
Phase 3Large-scale testing
5(50.0%)
Phase 4Post-market surveillance
2(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.0%

9 of 10 finished

Non-Completion Rate

10.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(9)
Terminated(1)

Detailed Status

Completed9
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
90.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (10.0%)
Phase 22 (20.0%)
Phase 35 (50.0%)
Phase 42 (20.0%)

Trials by Status

terminated110%
completed990%

Recent Activity

0 active trials
Showing 5 of 10
completedphase_2

Aztreonam for Pharyngeal Gonorrhea

NCT03867734
completedphase_4

Aztreonam for Inhalation Solution (AZLI) for the Treatment of Exacerbations of Cystic Fibrosis

NCT02894684
completedphase_3

Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012)

NCT02276482
completedphase_4

Antibiotic Prophylaxis for Transrectal Prostate Biopsy

NCT01659866
completedphase_1

Phase 1 Study to Evaluate DDI, PK, Safety, Tolerability of SPR741

NCT03376529
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT03867734Phase 2

Aztreonam for Pharyngeal Gonorrhea

Completed
NCT02894684Phase 4

Aztreonam for Inhalation Solution (AZLI) for the Treatment of Exacerbations of Cystic Fibrosis

Completed
NCT02276482Phase 3

Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012)

Completed
NCT01659866Phase 4

Antibiotic Prophylaxis for Transrectal Prostate Biopsy

Completed
NCT03376529Phase 1

Phase 1 Study to Evaluate DDI, PK, Safety, Tolerability of SPR741

Completed
NCT01984684Phase 3

Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Completed
NCT01811732Phase 3

Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Completed
NCT01499277Phase 3

Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections

Completed
NCT02202135Phase 3

Evaluation of Ceftaroline Fosamil vs Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections.

Terminated
NCT00633152Phase 2

Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections

Completed

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10